STOCK TITAN

[144] The Brink's Company SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

The Brink's Company (BCO) filed a Form 144 proposing the sale of 475 common shares through Merrill Lynch on the NYSE with an aggregate market value of $50,399. Those shares represent a very small portion of the company's 41,662,286 outstanding shares, and the sale is scheduled approximately for 08/11/2025. The securities were acquired under a stock plan on 12/07/2023. The filing reports no securities sold in the past three months and includes the filer’s representation that there is no undisclosed material adverse information about the issuer.

The Brink's Company (BCO) ha depositato un Form 144 proponendo la vendita di 475 azioni ordinarie tramite Merrill Lynch sul NYSE per un valore di mercato complessivo di $50.399. Queste azioni rappresentano una porzione molto piccola delle 41.662.286 azioni in circolazione della società, e la vendita è prevista approssimativamente per il 11/08/2025. I titoli sono stati acquisiti in base a un piano azionario il 07/12/2023. La comunicazione riporta che non sono stati venduti titoli negli ultimi tre mesi e include la dichiarazione del dichiarante che non esistono informazioni negative materiali non divulgate sull'emittente.

The Brink's Company (BCO) presentó un Form 144 proponiendo la venta de 475 acciones ordinarias a través de Merrill Lynch en la NYSE por un valor de mercado agregado de $50.399. Esas acciones representan una porción muy pequeña de las 41.662.286 acciones en circulación de la compañía, y la venta está prevista aproximadamente para el 11/08/2025. Los títulos se adquirieron en virtud de un plan de acciones el 07/12/2023. La presentación informa que no se vendieron valores en los últimos tres meses e incluye la declaración del declarante de que no existe información material adversa no divulgada sobre el emisor.

The Brink's Company (BCO)가 NYSE에서 Merrill Lynch를 통해 총 시장 가치 $50,399에 해당하는 475 보통주의 매각을 제안하는 Form 144를 제출했습니다. 해당 주식은 회사의 총 발행주식 41,662,286주 중 극히 일부에 해당하며, 매각 예정일은 대략 2025년 8월 11일입니다. 이 증권은 주식 계획에 따라 2023년 12월 7일에 취득되었습니다. 제출서류는 최근 3개월 내에 매각된 증권이 없다고 보고하며, 제출인이 발행회사에 대한 미공개 중대한 불리한 정보가 없음을 진술하고 있습니다.

The Brink's Company (BCO) a déposé un Form 144 proposant la vente de 475 actions ordinaires par l'intermédiaire de Merrill Lynch sur le NYSE pour une valeur de marché totale de $50.399. Ces actions représentent une part très faible des 41.662.286 actions en circulation de la société, et la vente est prévue approximativement pour le 11/08/2025. Les titres ont été acquis dans le cadre d'un plan d'actions le 07/12/2023. Le dépôt indique qu'aucun titre n'a été vendu au cours des trois derniers mois et comprend la déclaration du déclarant qu'il n'existe pas d'information défavorable importante non divulguée concernant l'émetteur.

The Brink's Company (BCO) hat ein Form 144 eingereicht, in dem der Verkauf von 475 Stammaktien über Merrill Lynch an der NYSE mit einem Gesamtmarktwert von $50.399 vorgeschlagen wird. Diese Aktien stellen einen sehr kleinen Anteil an den 41.662.286 ausstehenden Aktien des Unternehmens dar, und der Verkauf ist ungefähr für den 11.08.2025 geplant. Die Wertpapiere wurden im Rahmen eines Aktienplans am 07.12.2023 erworben. Die Meldung gibt an, dass in den vergangenen drei Monaten keine Wertpapiere verkauft wurden, und enthält die Erklärung des Meldenden, dass keine nicht offengelegte wesentliche nachteilige Information über den Emittenten vorliegt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: The notice covers a very small insider sale; immaterial to company valuation given the tiny percentage of outstanding stock.

The Form 144 documents a proposed sale of 475 shares valued at $50,399. With 41,662,286 shares outstanding, this position represents an immaterial fraction of equity (well under 0.01%). The filing indicates acquisition under a stock plan on 12/07/2023 and lists Merrill Lynch as the broker for an anticipated sale on 08/11/2025. There are no reported sales in the prior three months. From a valuation perspective, this disclosure is routine and unlikely to affect market dynamics.

TL;DR: Routine compliance disclosure under Rule 144; no governance concerns arise from the information provided.

The filing shows standard Rule 144 reporting: identification of the securities, acquisition method (a stock plan), broker (Merrill Lynch), and an approximate sale date. The filer affirms there is no undisclosed material adverse information. There are no red flags such as recent large insider disposals or conflicting disclosures. Procedurally, the Form 144 appears to satisfy required public notice obligations for an intended sale.

The Brink's Company (BCO) ha depositato un Form 144 proponendo la vendita di 475 azioni ordinarie tramite Merrill Lynch sul NYSE per un valore di mercato complessivo di $50.399. Queste azioni rappresentano una porzione molto piccola delle 41.662.286 azioni in circolazione della società, e la vendita è prevista approssimativamente per il 11/08/2025. I titoli sono stati acquisiti in base a un piano azionario il 07/12/2023. La comunicazione riporta che non sono stati venduti titoli negli ultimi tre mesi e include la dichiarazione del dichiarante che non esistono informazioni negative materiali non divulgate sull'emittente.

The Brink's Company (BCO) presentó un Form 144 proponiendo la venta de 475 acciones ordinarias a través de Merrill Lynch en la NYSE por un valor de mercado agregado de $50.399. Esas acciones representan una porción muy pequeña de las 41.662.286 acciones en circulación de la compañía, y la venta está prevista aproximadamente para el 11/08/2025. Los títulos se adquirieron en virtud de un plan de acciones el 07/12/2023. La presentación informa que no se vendieron valores en los últimos tres meses e incluye la declaración del declarante de que no existe información material adversa no divulgada sobre el emisor.

The Brink's Company (BCO)가 NYSE에서 Merrill Lynch를 통해 총 시장 가치 $50,399에 해당하는 475 보통주의 매각을 제안하는 Form 144를 제출했습니다. 해당 주식은 회사의 총 발행주식 41,662,286주 중 극히 일부에 해당하며, 매각 예정일은 대략 2025년 8월 11일입니다. 이 증권은 주식 계획에 따라 2023년 12월 7일에 취득되었습니다. 제출서류는 최근 3개월 내에 매각된 증권이 없다고 보고하며, 제출인이 발행회사에 대한 미공개 중대한 불리한 정보가 없음을 진술하고 있습니다.

The Brink's Company (BCO) a déposé un Form 144 proposant la vente de 475 actions ordinaires par l'intermédiaire de Merrill Lynch sur le NYSE pour une valeur de marché totale de $50.399. Ces actions représentent une part très faible des 41.662.286 actions en circulation de la société, et la vente est prévue approximativement pour le 11/08/2025. Les titres ont été acquis dans le cadre d'un plan d'actions le 07/12/2023. Le dépôt indique qu'aucun titre n'a été vendu au cours des trois derniers mois et comprend la déclaration du déclarant qu'il n'existe pas d'information défavorable importante non divulguée concernant l'émetteur.

The Brink's Company (BCO) hat ein Form 144 eingereicht, in dem der Verkauf von 475 Stammaktien über Merrill Lynch an der NYSE mit einem Gesamtmarktwert von $50.399 vorgeschlagen wird. Diese Aktien stellen einen sehr kleinen Anteil an den 41.662.286 ausstehenden Aktien des Unternehmens dar, und der Verkauf ist ungefähr für den 11.08.2025 geplant. Die Wertpapiere wurden im Rahmen eines Aktienplans am 07.12.2023 erworben. Die Meldung gibt an, dass in den vergangenen drei Monaten keine Wertpapiere verkauft wurden, und enthält die Erklärung des Meldenden, dass keine nicht offengelegte wesentliche nachteilige Information über den Emittenten vorliegt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Brink's (BCO) disclose in this Form 144?

The filing proposes the sale of 475 common shares through Merrill Lynch on the NYSE with an aggregate market value of $50,399 and an approximate sale date of 08/11/2025.

How many shares are involved and how large is the position relative to outstanding shares?

The notice covers 475 shares versus 41,662,286 shares outstanding, making the position an immaterial fraction of total equity.

When and how were the shares acquired?

The securities were acquired on 12/07/2023 under a stock plan (acquisition listed as from the issuer).

Has the filer sold other Brink's securities in the past three months?

No. The Form 144 states Nothing to Report for securities sold during the past three months.

Which broker is named in the Form 144 for this sale?

The broker listed for the proposed sale is Merrill Lynch, and the sale is to be executed on the NYSE.
Brinks Co

NYSE:BCO

BCO Rankings

BCO Latest News

BCO Latest SEC Filings

BCO Stock Data

4.17B
41.20M
0.95%
102.2%
2.69%
Security & Protection Services
Arrangement of Transportation of Freight & Cargo
Link
United States
RICHMOND